Loading
Gyrodyne, LLC Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by TOWERVIEW LLC, was filed 12 Aug 2024.
Gyrodyne, LLC: what insiders have been doing
Headquartered in United States, Gyrodyne, LLC belongs to the Real Estate sector and traces its origins to 1946. Filings by its managers are published through SEC (Form 4). The past year has been quiet: not a single insider filing for Gyrodyne, LLC. The previous disclosure was published on 8 September 2025.
Since 2021, the database holds 3 purchases and 6 sales by insiders of the company.
For comparison within the same sector, see the insider buying recorded at Agree Realty Corp and Simon Property Group Inc /DE/. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
20
Thresholds
n/a
Buy Volume
€28,181
3 ops. · all time
Sell Volume
€444,062
6 ops. · all time
Who traded when
BuySaleTowerview LLC3 sales
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2022FY ended December 2022 · cache
US$5.40
Analyst consensus
Income statement
RevenueUS$2.4M
EBITDA-US$3.1M-128% margin
Net income-US$2.7M-137.1% margin
Valuation
PER (trailing)45.0x
P/Book0.2x
Beta0.52
Balance sheet & cash
Market capUS$11.9M
Total debtUS$9.8M
Debt / Equity69%
Profitability & ownership
% insiders26.6%
% institutions40.2%
Last declaration on 8 September 2025
Declarations20 total
1,973 shares@ US$12.551.5% of flowCommon SharesSEC:0001166573-25-000005:0
8,698 shares@ US$8.000.63% mcap50.0% of flowCOMMON SHARES OF LIMITED LIABILITY COMPANY INTERESTSSEC:0001246739-25-000003:0
916 shares@ US$12.100.7% of flowCommon SharesSEC:0001166573-25-000004:0
1,216 shares@ US$12.100.9% of flowCommon SharesSEC:0001166573-25-000003:0
3,270 shares@ US$11.752.5% of flowCommon SharesSEC:0001166573-24-000009:0
1,000 shares@ US$7.770.5% of flowCommon SharesSEC:0001166573-24-000007:0
Canonical exit: 7 Nov 2024 (T+90)
424 shares@ US$7.830.2% of flowCommon SharesSEC:0001166573-24-000005:0
Canonical exit: 30 Jul 2024 (T+90)
2,434 shares@ US$7.841.3% of flowCommon SharesSEC:0001166573-24-000004:0
Canonical exit: 15 Jul 2024 (T+90)
4,368 shares@ US$7.99373.3% of flowCOMMON SHARES OF LIMITED LIABILITY COMPANY INTERESTSSEC:0001244352-24-000002:0
9,690 shares@ US$8.0014.7% of flowCOMMON SHARES OF LIMITED LIABILITY COMPANY INTERESTSSEC:0001380362-24-000001:0
346 shares@ US$8.000.6% of flowCOMMON SHARES OF LIMITED LIABILITY COMPANY INTERESTSSEC:0001652934-24-000001:0
47,895 shares@ US$8.0035.1% of flowCOMMON SHARES OF LIMITED LIABILITY COMPANY INTERESTSSEC:0001244352-24-000001:0
8,672 shares@ US$8.0013.4% of flowCOMMON SHARES OF LIMITED LIABILITY COMPANY INTERESTSSEC:0001246739-24-000001:0
3,632 shares@ US$8.00100.0% of flowCOMMON SHARES OF LIMITED LIABILITY COMPANY INTERESTSSEC:0001437749-24-007862:0
177,541 shares@ US$8.0092.4% of flowCommon SharesSEC:0001166573-24-000003:0
20,362 shares@ US$21.6099.4% of flowCOMMON SHARES OF LIMITED LIABILITY COMPANY INTERESTSSEC:0001652934-23-000002:0
20,362 shares@ US$21.6085.3% of flowCOMMON SHARES OF LIMITED LIABILITY COMPANY INTERESTSSEC:0001380362-23-000003:0
30,542 shares@ US$21.6061.7% of flowCOMMON SHARES OF LIMITED LIABILITY COMPANY INTERESTSSEC:0001244352-23-000003:0
20,362 shares@ US$21.6086.6% of flowCOMMON SHARES OF LIMITED LIABILITY COMPANY INTERESTSSEC:0001246739-23-000002:0
30,000 shares@ US$13.04100.0% of flowCommon StockSEC:0001104659-21-111223:0
20 of 20 declarations
About Gyrodyne, LLC
Gyrodyne, LLC is a U.S.-listed real estate company trading on NASDAQ under the ticker GYRO. For French-speaking investors, the key point is that Gyrodyne is not a broad-based REIT with a large national portfolio; it is a concentrated, asset-driven real estate platform focused on extracting value from a small number of properties. The company is organized as a New York limited liability company and is headquartered in Smithtown, New York. Its operating history on Long Island spans more than 70 years, giving it a long local footprint and deep familiarity with its core submarkets. ([gyrodyne.com](https://gyrodyne.com/?utm_source=openai))
Gyrodyne’s core business today is the ownership, operation, and management of a portfolio of medical office and industrial real estate, combined with the pursuit of entitlements and development rights tied to those assets. The company states that its properties are located in Suffolk County, at Flowerfield, and in Westchester County, at Cortlandt Manor, both in New York State. It reports that it owns and manages more than 161,000 square feet of rentable space across nine buildings, indicating a relatively small but focused operating base. ([sec.gov](https://www.sec.gov/Archives/edgar/data/1589061/000143774926010078/gyrllc20251231_10k.htm?utm_source=openai))
Read moreShow less
Strategically, Gyrodyne is positioned in a niche healthcare real estate segment that has historically benefited from durable demand for medical office space and related uses. The company notes that it was previously a publicly traded REIT and later sharpened its focus on healthcare-related real estate. Its competitive edge is less about scale and more about asset quality, site location, and optionality: value creation can come from entitlement work, redevelopment potential, and eventual monetization of land and buildings. This makes the name more of a special situation than a conventional property operator. ([gyrodyne.com](https://gyrodyne.com/company_about.php?utm_source=openai))
Recent developments reinforce that special-situation profile. In its 2025 annual report, Gyrodyne states that its financial statements are prepared on a liquidation basis, which signals a strategy centered on orderly realization of value rather than long-term portfolio expansion. The company disclosed a net realizable value of $53.99 million for remaining real estate at December 31, 2025, with the year-over-year increase driven mainly by entitlement status and market conditions. In August 2025, Gyrodyne also highlighted development-related progress and potential economic output from the campus, while SEC Form 4 filings in 2025 indicate ongoing insider transaction activity that market participants may monitor closely. ([sec.gov](https://www.sec.gov/Archives/edgar/data/0001589061/000143774926010078/gyrllc20251231_10k.htm?utm_source=openai))
In short, Gyrodyne is a small-cap U.S. real estate company listed on NASDAQ in the United States, best understood as a value-realization story tied to New York land, medical office assets, and the success of entitlement and redevelopment initiatives.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
